Escitalopram Oxalate
Product Images NDC 10544-224

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Escitalopram Oxalate (NDC 10544-224). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure-escitalopram Sulfate (Chemical Structure Escitalopram Sulfate)

FDA Label Image

Label Graphic-escitalopram 10 mg 30 Tablets (Label Graphic Escitalopram 10 mg 30 Tablets)

This is a description of medication called Escitalopram Tablets, USP with dosage of 10mg. The box contains 30 tablets and it is available only with a prescription. It comes with a package insert with the dosage information. The drug should be stored at controlled room temperature ranging from 20°-25°C (68"-77°F) with permissible excursions up to 15°-30°C (3% 86°F). The information about the manufacturer and the lot number with expiry date are provided on the box. There are separate details for 4 boxes with different lot numbers and no information related to any side effects.*

FDA Label Image

Label Graphic-escitalopram 15 mg 30 Tablets (Label Graphic Escitalopram 15 mg 30 Tablets)

This is a description of a medication called Escitalopram Tablets, USP 20mg that comes in a package of 30 tablets. It is a prescription drug that should be stored within controlled room temperature of 20°-25°C (68°77°F) and it is only available with a prescription. The package insert should be read for the dosage. The medication is to be kept in a light-resistant container, out of children's reach, and excursions are permitted between 15%-30°C (59°-85°F). It is packaged by Blenheim Pharmacal, Inc., and the lot number is BPODODODOD with an expiration date of 00/00/0000. There are several other variations of the medication that have the same NDC number, with different manufacturing codes, lot numbers, and expiration dates.*

FDA Label Image

Label Graphic-escitalopram 5 mg 30 Tablets (Label Graphic Escitalopram 5 mg 30 Tablets)

This is information about the drug Escitalopram in the form of tablets. It is available in 5mg strength and packaged in a container with 30 tablets. This medicine is only available by prescription and must be stored at a controlled room temperature of 20°-25°C (5B-77°F). The lot number and expiration date are also mentioned on the label. It is important to keep this medicine out of the reach of children.*

FDA Label Image

1 (Image 01)

This is a table showing treatment-emergent adverse reactions observed in patients with Major Depressive Disorder. The reactions listed occurred with a frequency of greater than 2% and were greater than placebo. The table compares the reactions associated with Escitalopram Oxalate versus Placebo administrations. The reactions have been categorized under Autonomic Nervous System Disorders, Central & Peripheral Nervous System Disorders, Gastrointestinal Disorders, General, Psychiatric Disorders, Respiratory System Disorders, and Urogenital. Ejaculation Disorder, Impotence, and Anorgasmia were observed in males and Insomnia and Somnolence in females.*

FDA Label Image

2 (Textescitalopram Figure 02)

This is a table showing the treatment-emergent adverse reactions with a frequency of greater than 2% and greater than placebo for Generalized Anxiety Disorder. The adverse reactions are grouped by body system including Autonomic Nervous System Disorders, Central & Peripheral Nervous System Disorders, Gastrointestinal Disorders, General, Musculoskeletal System Disorder, Psychiatric Disorders, Respiratory System Disorders, and Trogenital. The adverse reactions with their corresponding percentage are listed for both Escitalopram and Placebo groups. The denominators used for the calculations are also provided.*

FDA Label Image

Logo (Textescitalopram Figure 04)

FDA Label Image

1 (Textescitalopram Figure 05)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.